| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.5M | +49.0% |
| SG&A Expense | $157.9M | +5195.9% |
| Operating Income | -$160.4M | -9627.5% |
| Pre-tax Income | $0 | — |
| Income Tax | $0 | — |
| Net Income | -$160.4M | — |
| EPS (Basic) | -$0.78 | -3800.0% |
| EPS (Diluted) | -$0.78 | -3800.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20K | +66.7% |
| Current Assets | $596K | +3433.3% |
| Total Assets | $1.3M | -85.1% |
| Current Liabilities | $10.2M | +34.7% |
| Total Liabilities | $22.1M | +111.8% |
| Stockholders' Equity | -$20.8M | -99.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.9M | -678.8% |
| Financing Cash Flow | $5.9M | +113.7% |